The North America infusion pumps market is expected to reach US$ 6,974.6 Mn in 2025 from US$ 4,488.1 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2025.
The growth of the market is driven by the factors such as, increasing incidence of chronic diseases, increasing number of surgical procedures performed, growing and geriatric population. However, the market is likely to slower down its growth due to the factors such as frequent product recalls of infusion pumps and stringent regulatory requirements.
Infusion pumps are widely used in hospitals, nursing homes, and some types of infusion pumps can be used at home too. Infusion pumps are used to deliver medications such as, insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Thus rising prevalence of chronic diseases like cancer, diabetes and others drives the market growth. Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period. Also, according to the World Health Organization in 2018, cancer was the second leading cause of death across the globe, and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, 1,735,350 new cancer cases were diagnosed in 2018. Infusion pumps are also used to treat heart failure that helps in relieving and controlling the symptoms. According to Emory Healthcare in 2018, around 5 million people in America suffer from congestive heart failure (CHF). Thus, the increasing incidences of chronic diseases poses several opportunities for the infusion pumps market to grow during the forecast period in the region.
US is expected to lead the market in the North America region owing to increasing prevalence of diabetic diseases, obesity, hormonal dysfunctions and others in the country. Whereas, steady drug injection is majorly required, rapid growth of the geriatric population, increasing awareness among patient population, technological advancements in infusion pump and favorable reimbursement policies are expected to fuel the growth of infusion pumps market in the US. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
NORTH AMERICA INFUSION PUMPS – MARKET SEGMENTATION
By Type
By Application
By End User
By Geography
Company Profiles
Ambulatory Pumps
Diabetes
Hospitals & Clinics
North America
BD
Enteral Pumps
Chemotherapy
Ambulatory Surgical Centers
US
Terumo Corporation
PCA Pumps
Gastrointestinal Diseases
Homecare
Canada
F. Hoffman-La Roche Ltd
Insulin Pumps
Pediatrics
Mexico
B. Braun Melsungen AG
Volumetric Pumps
Medtronic
Smart Pumps
Baxter
Elastomeric Pumps
Smith Medical
Syringe Pumps
Moog Inc.
Accessories
ICU Medical, Inc.
Insulet Corporation
North America Infusion Pumps Strategic Insights
Strategic insights for the North America Infusion Pumps provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
North America Infusion Pumps Report Scope
Attribute
Details
Market Size (2018)
US$ 4,488.1 Million
Market Size (2025)
US$ 6,974.6 Million
Global CAGR (2019-2025)
6.5%
Historical Data
2016-2017
Forecast Period
2019-2025
Segments Covered
Type: Ambulatory Pumps, Volumetric Pumps, Syringe Pumps and Accessories Application: Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics End User: Hospitals & Clinics, Ambulatory Surgical Centers, Homecare
Regions Covered
North America (US, Canada, Mexico)
Market Leaders
BD, Terumo Corporation, F. Hoffman-La Roche Ltd, B. Braun Melsungen AG, Medtronic, Baxter, Smith Medical, Moog Inc., ICU Medical, Inc., Insulet Corporation
North America Infusion Pumps Regional Insights
The geographic scope of the North America Infusion Pumps refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
